Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
CN¥7.00 - CN¥10.88
Next Earnings Date
Apr 30 2025
Next Earnings Date
Apr 30 2025
Latest price
Market Cap | CN¥14.12B |
EV | CN¥14.24B |
Shares Outstanding | 1.93B |
Beta | 0.24 |
Analyst Rating | BUY |
Analyst Target Price | CN¥10.53 |
P/E 2024E | - |
P/Revenue 2024E | 6.82x |
Revenue | 1.70% |
EPS | 8.70% |
Operating Cash Flow | -10.30% |
Free Cash Flow | -19.20% |
Revenue | 1.00% |
EPS | -4.70% |
Operating Cash Flow | 5.80% |
Free Cash Flow | 8.50% |
Gross Margin 2024E | 74.08% |
Net Profit Margin 2024E | 1.61% |
ROE 2024E | 0.73% |
ROCE 2023 | 16.98% |
DPS 2024E | CN¥0.11 |
Payout Ratio 2024E | 550.00% |
Div. Yield 2024E | 1.43% |
DPS Last 3Y CAGR | 6.00% |
Price
%
1M
3M
6M
1Y
3Y
5Y
Tonghua Dongbao Pharmaceutical Co., Ltd.
600867
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Chun, Sheng Leng
Employees
3,196
Website
www.thdb.comIPO Date
1994-08-24
Headquarters
Dongbao New Village, Tonghua County, Tonghua, Jilin Province, 134123, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved